Bolt Biotherapeutics Inc Forecast, price target & analysts
Bolt Biotherapeutics Inc Target price 2025 - Analyst rating & recommendation
Bolt Biotherapeutics Inc Classifications & Recommendation:
Bolt Biotherapeutics Inc Price Target
| Target Price | $13.77 |
| Price | $4.57 |
| Potential |
201.31%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Bolt Biotherapeutics Inc 2026 .
The average Bolt Biotherapeutics Inc target price is $13.77.
This is
201.31%
register free of charge
$78.75
1,623.19%
register free of charge
$6.06
32.60%
register free of charge
|
|
| A rating was issued by 11 analysts: 7 Analysts recommend Bolt Biotherapeutics Inc to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bolt Biotherapeutics Inc stock has an average upside potential 2026 of
201.31%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 7.69 | 4.52 |
| 2.41% | 41.22% | |
| EBITDA Margin | -864.24% | -2,758.20% |
| 8.39% | 219.15% | |
| Net Margin | -820.81% | -996.10% |
| 6.53% | 21.36% |
7 Analysts have issued a sales forecast Bolt Biotherapeutics Inc 2025 . The average Bolt Biotherapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Bolt Biotherapeutics Inc EBITDA forecast 2025. The average Bolt Biotherapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Bolt Biotherapeutics Inc Analysts have issued a net profit forecast 2025. The average Bolt Biotherapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -33.06 | -23.45 |
| 9.67% | 29.07% | |
| P/E | negative | |
| EV/Sales | negative |
7 Analysts have issued a Bolt Biotherapeutics Inc forecast for earnings per share. The average Bolt Biotherapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Bolt Biotherapeutics Inc...
Current Bolt Biotherapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Lake Street |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | May 20 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | May 13 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Lake Street:
Locked
➜
Locked
|
Aug 15 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
May 20 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
